IRCS pharmaceutical firms suffer $83m wartime damage
Two pharmaceutical and medical equipment companies affiliated with the Iranian Red Crescent Society (IRCS) suffered an estimated $83.3 million (1.5 trillion tomans) in damages during the US-Israeli war against Iran, the head of the organization’s medical procurement body told ISNA.
Mohammad Reza Shanesaz, head of the Iranian Red Crescent Society’s Medical Procurement Organization, said nearby explosions during the 40-day war damaged the pharmaceutical and medical equipment companies.
He said laboratories, production halls and other sections of the companies were damaged, forcing the Medical Procurement Organization out of production for two days.
However, Shanesaz said employees, most of them women, quickly resumed operations.
“Without any fear, they immediately got to work, removed the obstacles that had halted production, and the company’s production resumed,” he said.
He added that both companies had also come under attack during the earlier 12-day Israeli-imposed war in June.
Shanesaz said preliminary estimates put the damage to the two companies at around 1.5 trillion tomans, though he said the figure would “certainly increase.”
He also said eight containers carrying materials needed for the production of hemodialysis filters had been seized aboard the vessel Tosca.
He said obtaining the materials had been difficult and time-consuming, and that their seizure would complicate the production of medical equipment for dialysis patients until the cargo was released.